
Delpizin M 5mg/500mg Tablet SR
Marketer
Uniza Healthcare LLP
Salt Composition
Dapagliflozin (5mg) + Metformin (500mg)
Overview Delpizin M 5mg/500mg Tablet SR
Diabetic patients with type 2 mellitus may find relief with Delpizin M 5mg/500mg SR tablets, a dual-action medication designed to manage elevated blood glucose. This helps mitigate the risk of severe diabetic complications and contributes to cardiovascular health. Delpizin M 5mg/500mg SR can be taken with meals, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation requires their consultation to avoid potential blood sugar spikes and resulting complications such as renal impairment or vision loss. This medication is a component of a comprehensive diabetes management plan, encompassing dietary modifications, exercise, and weight management as directed by your doctor. Commonly reported side effects include upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea), and dehydration (mitigated by increased fluid intake). Genital fungal infections may occur; proper hygiene is crucial for prevention. Prior to initiating treatment, disclose any kidney or liver dysfunction, urinary tract infections, diuretic use, or pregnancy/breastfeeding status to your doctor. Limit alcohol consumption during treatment to minimize potential adverse effects. Regular blood glucose monitoring is recommended throughout treatment.
Uses of Delpizin M 5mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Delpizin M 5mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Delpizin M 5mg/500mg SR Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer this medication with food.
Common Side effects of Delpizin M 5mg/500mg Tablet SR:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Delpizin M 5mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Delpizin M 5mg/500mg Sustained-Release tablets should be administered with a meal.
How Delpizin M 5mg/500mg Tablet SR works:
Delpizin M 5mg/500mg Extended-Release tablets combine dapagliflozin and metformin, two agents that manage blood glucose levels. Dapagliflozin facilitates glucose excretion via the kidneys, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness. This dual action optimizes glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Delpizin M 5mg/500mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The extended-release Delpizin M 5mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Delpizin M 5mg/500mg tablets are likely not suitable for breastfeeding mothers. Available human evidence indicates potential drug transfer via breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Delpizin M 5mg/500mg sustained-release tablets to individuals with impaired renal function. Dosage modification of Delpizin M 5mg/500mg sustained-release tablets might be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should use Delpizin M 5mg/500mg sustained-release tablets cautiously. Dosage modification of Delpizin M 5mg/500mg sustained-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Delpizin M 5mg/500mg Tablet SR :
Should you forget a Delpizin M 5mg/500mg Tablet SR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Delpizin M 5mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
